Particularly, increased FADS1 expression is positively associated with tumor formation (primary tumor) and cancer progression (recurrent tumor) among non-brain cancers and negatively associated with cancer progression (recurrent tumor) in brain cancers. Here, FADS1 is linked to neoplasm.